Jon Chick

Statistics

Publications

Citations

H-Index

Active since

2005

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Jon Chick is an author at The University of Texas at San Antonio Health Science Center specializing in oncology, pharmacology, and cancer pharmacology.

Publications per year

2005–2013

Publications

First-in-Human Phase I Trial of Two Schedules of OSI-930, a Novel Multikinase Inhibitor, Incorporating Translational Proof-of-Mechanism Studies

Timothy A. Yap, Hendrik-Tobias Arkenau, D. Ross Camidge et al. · Clinical Cancer Research · 2013 · 34 citations · Full text

Medicine, Oncology, Pharmacology +16

Phase I Study of OSI-7904L, a Novel Liposomal Thymidylate Synthase Inhibitor in Patients with Refractory Solid Tumors

Gernot Beutel, Hilary Glen, Patrick Schöffski et al. · Clinical Cancer Research · 2005 · 29 citations · Full text

Pharmacy, Oncology, Pharmacology +12

Phase I, Pharmacokinetic and Biological Correlative Study of OSI-7904L, a Novel Liposomal Thymidylate Synthase Inhibitor, and Cisplatin in Patients with Solid Tumors

Alejandro D. Ricart, Jordan Berlin, Kyriakos P. Papadopoulos et al. · Clinical Cancer Research · 2008 · 17 citations · Full text

Pharmacy, Oncology, Pharmacology +17

1–3 of 3